Phase 2 data showed up to 24.2% weight loss at 48 weeks, the highest ever recorded for any obesity medication
Corresponsing Author Chaiyawat Aonsri Lipidomics Research Highlight New Thiazolidin-4-one Derivatives: A Promising Lead for Fatty Liver Disease We are excited to share our latest findings on the development of 2,3-diaryl-1,3-thiazolidin-4-ones as potent lipid-lowering agents
Disc electrophoresis-II
The single nucleotide polymorphism rs6923761, known as the Gly168Ser variant, is the most extensively studied GLP-1 receptor variation
If you have a temperature above 38C, productive cough, or significant respiratory symptoms, this strongly suggests an infectious cause rather than medication side effects
CrossRef Relationship between metabolic dysfunction-associated steatotic liver disease and cardiovascular mortality risk in individuals with CKM stages 02: Mediating roles of inflammation and insulin resistance Zhuoxing Li, Qianyu Yang, Li Zang, Hongwei Leng, Panpan Qin, Simeng Li, Buyuan Tian, Xumao Deng, Yun Sun, Xiang Xiao Diabetes Research and Clinical Practice .2026